Ryan Crowe
Investor Relations Contact at REGENERON PHARMACEUTICALS, INC.
Profile
Ryan Crowe is currently the Head of Investor Relations at Regeneron Pharmaceuticals, Inc. Prior to this, he worked as the Senior Director of Investor Relations at Pfizer Inc. and as the Vice President of Investor Relations at Myovant Sciences Ltd.
He received his undergraduate degree from Drexel University and his MBA from The Leonard N Stern School of Business.
Ryan Crowe active positions
| Companies | Position | Start |
|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | Investor Relations Contact | - |
Former positions of Ryan Crowe
| Companies | Position | End |
|---|---|---|
| MYOVANT SCIENCES LTD. | Investor Relations Contact | - |
| PFIZER, INC. | Public Communications Contact | - |
Training of Ryan Crowe
| Drexel University | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| REGENERON PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Myovant Sciences Ltd.
 Myovant Sciences Ltd. BiotechnologyHealth Technology Myovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for the treatment of women's health and endocrine diseases. It offers ORGOVYXTM, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist for the treatment of adult patients with advanced prostate cancer, and MYFEMBREE, which is taken for the management of heavy menstrual bleeding associated with uterine fibroids. The company was founded on February 2, 2016 and is headquartered in London, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Ryan Crowe
